398 related articles for article (PubMed ID: 25530129)
1. The impact of asthma exacerbations and preventive strategies.
Graham LM; Eid N
Curr Med Res Opin; 2015 Apr; 31(4):825-35. PubMed ID: 25530129
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
Sin DD; Man J; Sharpe H; Gan WQ; Man SF
JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies to reduce asthma exacerbations.
O'Byrne PM
J Allergy Clin Immunol; 2011 Aug; 128(2):257-63; quiz 264-5. PubMed ID: 21531015
[TBL] [Abstract][Full Text] [Related]
4. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
Tzortzaki EG; Georgiou A; Kampas D; Lemessios M; Markatos M; Adamidi T; Samara K; Skoula G; Damianaki A; Schiza S; Tzanakis N; Siafakas NM
Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
[TBL] [Abstract][Full Text] [Related]
5. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
Chipps BE; Figliomeni M; Spector S
Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategies for asthma].
Korn S; Taube C; Buhl R
Internist (Berl); 2012 Apr; 53(4):429-38; quiz 438-9. PubMed ID: 22349173
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective analysis of omalizumab in patients with severe allergic asthma].
Padullés Zamora N; Comas Sugrañes D; Méndez Cabaleiro N; Figueras Suriol A; Jodar Masanes R
Farm Hosp; 2013; 37(5):399-405. PubMed ID: 24128103
[TBL] [Abstract][Full Text] [Related]
9. Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.
Grimaldi-Bensouda L; Zureik M; Aubier M; Humbert M; Levy J; Benichou J; Molimard M; Abenhaim L;
Chest; 2013 Feb; 143(2):398-405. PubMed ID: 23505637
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
[TBL] [Abstract][Full Text] [Related]
11. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.
Thomson NC
Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.
Pelaia G; Gallelli L; Romeo P; Renda T; Busceti MT; Proietto A; Grembiale RD; Marsico SA; Maselli R; Vatrella A
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):713-21. PubMed ID: 22122813
[TBL] [Abstract][Full Text] [Related]
13. [Latin-American Consensus on Difficult-to-Control Asthma. 2008 Update].
Drugs Today (Barc); 2008 Jun; 44 Suppl 3():1-43. PubMed ID: 19093041
[TBL] [Abstract][Full Text] [Related]
14. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
15. Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab.
Chen H; Eisner MD; Haselkorn T; Trzaskoma B
Respir Med; 2013 Jan; 107(1):60-7. PubMed ID: 23083840
[TBL] [Abstract][Full Text] [Related]
16. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
17. Difficult asthma: assessment and management, Part 2.
Fanta CH; Long AA
Allergy Asthma Proc; 2012; 33(4):313-23. PubMed ID: 22856632
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
[TBL] [Abstract][Full Text] [Related]
19. Childhood asthma: treatment update.
Courtney AU; McCarter DF; Pollart SM
Am Fam Physician; 2005 May; 71(10):1959-68. PubMed ID: 15926412
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of omalizumab in severe asthma with fungal sensitisation: a case report.
Di Stefano F; Cinti B; Antonicelli L
Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):56-9. PubMed ID: 24702879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
